One-year Outcomes of XIENCE Skypoint 48-mm Drug-Eluting Stents in Long Coronary Lesions: The SPIRIT 48 Trial.

Park, Ki E; Wu, Chiung-Jen; Chehab, Bassem; Maksoud, Aziz; Bertolet, Barry; Ying, Shih-Wa; Simoes, Tiessa; Pingle, Sandeep C; Chang, Chi-Jen

Park, Ki E; Wu, Chiung-Jen; Chehab, Bassem; Maksoud, Aziz; Bertolet, Barry; Ying, Shih-Wa; Simoes, Tiessa; Pingle, Sandeep C; Chang, Chi-Jen.

Afiliação

Park KE; Division of Cardiovascular Medicine, Malcom Randall VA Medical Center, University of Florida, Gainesville, Florida.
Wu CJ; Department of Cardiology, Chung-Gung Memorial Hospital, Kaohsiung, Taiwan.
Chehab B; Department of Medicine, Ascension Via Christi Hospital, University of Kansas, Wichita, Kansas.
Maksoud A; Department of Medicine, Cardiovascular Research Institute of Kansas, University of Kansas, Wichita, Kansas.
Bertolet B; Cardiac Catheterization Laboratory, North Mississippi Medical Center, Tupelo, Mississippi.
Ying SW; Abbott Vascular, Santa Clara, California.
Simoes T; Abbott Vascular, Santa Clara, California.
Pingle SC; Abbott Vascular, Santa Clara, California.
Chang CJ; Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Tapei, Taiwan.

J Soc Cardiovasc Angiogr Interv ; 2(4): 101001, 2023.

Article em En | MEDLINE | ID: mdl-39131646

Palavras-chave

coronary disease; drug-eluting stents; percutaneous coronary intervention

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Soc Cardiovasc Angiogr Interv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google